Follow
Martin Lauss
Martin Lauss
Department of Oncology, Clinical Sciences, Lund University, Sweden
Verified email at med.lu.se
Title
Cited by
Cited by
Year
Tertiary lymphoid structures improve immunotherapy and survival in melanoma
R Cabrita, M Lauss, A Sanna, M Donia, M Skaarup Larsen, S Mitra, ...
Nature 577 (7791), 561-565, 2020
15342020
A molecular taxonomy for urothelial carcinoma
G Sjödahl, M Lauss, K Lövgren, G Chebil, S Gudjonsson, S Veerla, ...
Clinical cancer research 18 (12), 3377-3386, 2012
9012012
Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
M Lauss, M Donia, K Harbst, R Andersen, S Mitra, F Rosengren, M Salim, ...
Nature communications 8 (1), 1738, 2017
3822017
Integrated genomic and gene expression profiling identifies two major genomic circuits in urothelial carcinoma
D Lindgren, G Sjödahl, M Lauss, J Staaf, G Chebil, K Lövgren, ...
PloS one 7 (6), e38863, 2012
2202012
Toward a molecular pathologic classification of urothelial carcinoma
G Sjödahl, K Lövgren, M Lauss, O Patschan, S Gudjonsson, G Chebil, ...
The American journal of pathology 183 (3), 681-691, 2013
2002013
Molecular stratification of metastatic melanoma using gene expression profiling: Prediction of survival outcome and benefit from molecular targeted therapy
H Cirenajwis, H Ekedahl, M Lauss, K Harbst, A Carneiro, J Enoksson, ...
Oncotarget 6 (14), 12297, 2015
1832015
A systematic study of gene mutations in urothelial carcinoma; inactivating mutations in TSC2 and PIK3R1
G Sjödahl, M Lauss, S Gudjonsson, F Liedberg, C Halldén, G Chebil, ...
PloS one 6 (4), e18583, 2011
1462011
A molecular pathologic framework for risk stratification of stage T1 urothelial carcinoma
O Patschan, G Sjödahl, G Chebil, K Lövgren, M Lauss, S Gudjonsson, ...
European urology 68 (5), 824-832, 2015
1412015
Infiltration of CD3+ and CD68+ cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors
G Sjödahl, K Lövgren, M Lauss, G Chebil, O Patschan, S Gudjonsson, ...
Urologic Oncology: Seminars and Original Investigations 32 (6), 791-797, 2014
1412014
NF1‐mutated melanoma tumors harbor distinct clinical and biological characteristics
H Cirenajwis, M Lauss, H Ekedahl, T Törngren, A Kvist, LH Saal, H Olsson, ...
Molecular oncology 11 (4), 438-451, 2017
1382017
Gene expression profiling of primary male breast cancers reveals two unique subgroups and identifies N-acetyltransferase-1 (NAT1) as a novel prognostic biomarker
I Johansson, C Nilsson, P Berglund, M Lauss, M Ringnér, H Olsson, ...
Breast Cancer Research 14, 1-15, 2012
1332012
Multiregion whole-exome sequencing uncovers the genetic evolution and mutational heterogeneity of early-stage metastatic melanoma
K Harbst, M Lauss, H Cirenajwis, K Isaksson, F Rosengren, T Törngren, ...
Cancer research 76 (16), 4765-4774, 2016
1302016
Molecular profiling reveals low-and high-grade forms of primary melanoma
K Harbst, J Staaf, M Lauss, A Karlsson, A Måsbäck, I Johansson, ...
Clinical cancer research 18 (15), 4026-4036, 2012
1192012
Genome-wide DNA methylation analysis of lung carcinoma reveals one neuroendocrine and four adenocarcinoma epitypes associated with patient outcome
A Karlsson, M Jönsson, M Lauss, H Brunnström, P Jönsson, Å Borg, ...
Clinical Cancer Research 20 (23), 6127-6140, 2014
1032014
Characterization of the drugged human genome
M Lauss, A Kriegner, K Vierlinger, C Noehammer
Future Medicine Ltd 8 (8), 1063-1073, 2007
842007
An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells
K Holm, J Staaf, M Lauss, M Aine, D Lindgren, PO Bendahl, ...
Breast Cancer Research 18, 1-20, 2016
822016
Efficient arsenic metabolism—the AS3MT haplotype is associated with DNA methylation and expression of multiple genes around AS3MT
KS Engström, MB Hossain, M Lauss, S Ahmed, R Raqib, M Vahter, ...
PloS one 8 (1), e53732, 2013
822013
Molecular and genetic diversity in the metastatic process of melanoma
K Harbst, M Lauss, H Cirenajwis, C Winter, J Howlin, T Törngren, A Kvist, ...
The Journal of pathology 233 (1), 39-50, 2014
792014
Escape from nonsense-mediated decay associates with anti-tumor immunogenicity
K Litchfield, JL Reading, EL Lim, H Xu, P Liu, M Al-Bakir, YNS Wong, ...
Nature communications 11 (1), 3800, 2020
772020
Monitoring of technical variation in quantitative high-throughput datasets
M Lauss, I Visne, A Kriegner, M Ringnér, G Jönsson, M Höglund
Cancer informatics 12, CIN. S12862, 2013
772013
The system can't perform the operation now. Try again later.
Articles 1–20